LINC01198 promoted the drug resistance in glioblastoma cells through upregulating neural precursor cells and developmentally downregulated 4, E3 ubiquitin-protein ligase (NEDD4-1) and phosphatase and tensin homolog (PTEN) [123]. Here, PTEN is linked to glioblastoma.